Bronchiectasis study: sputum type and health outcomes
Part of Lungs & breathing clinical trials.
This study is looking at people with bronchiectasis (a lung condition that causes coughing and mucus) to understand how different types of inflammation in sputum (mucus from the lungs) affect their health over time. It may help find better treatments for those with frequent lung infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with a BMI of 18 or higher.
- You have been diagnosed with bronchiectasis (not from cystic fibrosis) and had a CT scan in the last year.
- You have had at least 2 lung infections or flare-ups in the past year.
- You do not have COPD or asthma as your main lung condition.
- You have not had cancer (except certain skin or thyroid cancers) in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, HSK31858, for people with non-cystic fibrosis bronchiectasis (a lung condition causing chronic cough and infections). It aims to see if the drug reduces lung flare-ups and improves symptoms.
This study tests a new medicine for people with non-cystic fibrosis bronchiectasis. It aims to see if the drug can help reduce symptoms and improve quality of life.
This study looks at what factors are linked to flare-ups and serious outcomes in people with non–cystic fibrosis bronchiectasis. You may be followed because your lung scans and recent stability help researchers understand what predicts worsening.
This study looks at different types of bronchiectasis in Chinese patients to understand the disease better. It may involve additional tests like lung function and questionnaires.
This study helps doctors identify different types of bronchiectasis (a lung disease where airways are permanently widened and damaged) to better understand how the disease develops and progresses. By following patients over time and collecting medical information, researchers hope to create a system that predicts which patients will worsen and need different treatments.
This study helps doctors understand how severe your bronchiectasis is and predict when you might have flare-ups. You'll have routine tests over 12 months to help researchers learn more about this condition and improve future care.
Hear when a new Non-cystic Fibrosis Bronchiectasis (NCFBE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.